BioSpace News Archive

Sobi™ will present new data at the 63rd Annual Meeting of the American Society of Hematology (ASH) taking place from 11-14 December 2021 .

The Allen Institute announced the launch of the Allen Institute for Neural Dynamics, a new neuroscience research division focused on the mammalian brain’s computations that give rise to complex behaviors like decision making, learning and memory.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 16 new data abstracts from across its hematology/oncology development program will be presented at the 63rd American Society of Hematology (ASH) Annual Meeting, which will be held December 11-14, 2021.

The Flume Catheter Company Ltd. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the FLUME catheter in the United States.

Qynapse Inc. is pleased to sponsor the 14th Clinical Trials on Alzheimer’s Disease conference (CTAD) to be held from November 9-12, 2021 , in Boston, MA.

Transgene today announces its business update for the quarter ending September 30, 2021.

Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced six ePoster presentations on the BION-1301 and atrasentan clinical programs at ASN Kidney Week 2021.

Oncopeptides AB, a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, announces that the company has decided to reduce the activity level in the clinical development program with melflufen to increase the company’s cash runway and at the same time support the ongoing marketing authorization application process in Europe.

Vascular Therapies Today, the company announced the presentation of clinical results from its Phase 3 clinical trial (ACCESS 1) during the Late Breaking Clinical Trials section of the American Association of Nephrology Annual Meeting.

Results from PROTECT Trial Evaluating KRYSTEXXA ® (pegloticase injection) in Kidney Transplant Recipients with Uncontrolled Gout Presented as Part of American Society of Nephrology (ASN) Kidney Week